Mary Miller, Acrivon Therapeutics stock sale

Chief legal officer, SEC Form 4, filed on July 23, 2026
$1,008573 shares, average $1.76
Transaction date
July 21, 2026
Shares held after
82,194Direct ownership
Change in holding
−0.69%From the transactions in the filing
Filing rows
1All open market

Price context

ACRV daily close, Apr 20 to October 26, 2026
$2.39$1.38
Daily close
Sale
Trade average $1.76
Transaction price
$1.76Weighted average
Close on trade date
$1.75July 21, 2026
Latest close
$1.72October 26, 2026
Since the trade
−2.27%vs the trade average

Transactions in the filing

DateTransactionSecuritySharesPriceAmountAfter
Sale
Common stockDirect
573
$1.76
$1,008
82,194

Recent filings at Acrivon Therapeutics

Full history
PersonTransactionAmount or sharesDate
Mary MillerChief legal officer
Sale
$944
Mary MillerChief legal officer
Sale
$585
Michaela LevinOfficer
Grant
+30,000 shares
Peter Blume-JensenCEO
Sale
$30,969
Peter Blume-JensenCEO
Sale
$3,443
Eric DevroeCOO
Sale
$1,214
Erick GamelinOfficer
Sale
$804
Mary MillerChief legal officer
Sale
$372